Home › Glioblastoma › District of Columbia › Washington
Pag-aaral pangklinika para sa Glioblastoma sa Washington, DC
Isang pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Washington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Nagre-recruitPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Nagre-recruitPhase 2
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
- Children's National Medical Center, Washington D.C.
Study of Olutasidenib and Temozolomide in HGG
Nagre-recruitPhase 2
- Children's National Medical Center, Washington D.C.
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Nagre-recruitPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Nagre-recruitPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
Nagre-recruitObservasyonal na pag-aaral
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
- Children's National Medical Center, Washington D.C.
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
Nagre-recruitPhase 1
- Children's National Hospital, Washington D.C.
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Nagre-recruitPhase 1
- Children's National Hospital, Washington D.C.
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Nagre-recruitPhase 2
- Children's National Medical Center, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Nagre-recruitPhase 1/2
- Sibley Memorial Hospital, Washington D.C.
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Nagre-recruitPhase 1
- National Institutes of Health, Bethesda · 7 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi ang layo
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi ang layo
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
Nagre-recruitPhase 1/2
- Sibley Memorial Hospital, Washington D.C.
Pag-aaral para sa Glioblastoma sa ibang lungsod
- New York City, NY30 pag-aaral
- Boston, MA28 pag-aaral
- Houston, TX26 pag-aaral
- Los Angeles, CA24 pag-aaral
- Durham, NC20 pag-aaral
- San Francisco, CA17 pag-aaral
- Chicago, IL15 pag-aaral
- Miami, FL14 pag-aaral
- Columbus, OH14 pag-aaral
- Rochester, MN13 pag-aaral
- Jacksonville, FL13 pag-aaral
- Aurora, CO12 pag-aaral
Iba pang pag-aaral sa Washington
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer55 pag-aaral
- Kanser sa Suso46 pag-aaral
- Metastatic Cancer43 pag-aaral
- Kanser sa Baga41 pag-aaral
- Kanser sa Prostate38 pag-aaral
- Obesity33 pag-aaral
- Colorectal Cancer29 pag-aaral
- Sakit sa Puso at Ugat ng Dugo28 pag-aaral
- Kanser sa Pantog26 pag-aaral
- Acute Myeloid Leukemia24 pag-aaral
- Kanser sa Ovary23 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.